Skip to main content
SpringerLink
Log in

Bacterial Pericarditis

Diagnosis and Management

  • Therapy in Practice
  • Published:
American Journal of Cardiovascular Drugs Aims and scope Submit manuscript

Abstract

Bacterial pericarditis occurs by direct infection during trauma, thoracic surgery, or catheter drainage, by spread from an intrathoracic, myocardial, or subdiaphragmatic focus, and by hematogenous dissemination. The frequent causes are Staphylococcus and Streptococcus (rheumatic pancarditis), Haemophilus, and M. tuberculosis. In AIDS pericarditis, the incidence of bacterial infection is much higher than in the general population, with a high proportion of Mycobacterium avium-intracellulare infection. Purulent pericarditis is the most serious manifestation of bacterial pericarditis, characterized by gross pus in the pericardium or microscopically purulent effusion. It is an acute, fulminant illness with fever in virtually all patients. Chest pain is uncommon. Purulent pericarditis is always fatal if untreated. The mortality rate in treated patients is 40%, and death is mostly due to cardiac tamponade, systemic toxicity, cardiac decompensation, and constriction. Tuberculous infection may present as acute pericarditis, cardiac tamponade, silent (often large) relapsing pericardial effusion, effusive-constrictive pericarditis, toxic symptoms with persistent fever, and acute, subacute, or chronic constriction. The mortality in untreated patients approaches 85%. Urgent pericardial drainage, combined with intravenous antibacterial therapy (e. g. vancomycin 1g twice daily, ceftriaxone 1–2g twice daily, and ciprofloxacin 400 mg/ day) is mandatory in purulent pericarditis. Irrigation with urokinase or streptokinase, using large catheters, may liquify the purulent exudate, but open surgical drainage is preferable. The initial treatment of tuberculous pericarditis should include isoniazid 300 mg/day, rifampin 600 mg/day, pyrazinamide 15–30 mg/kg/day, and ethambutol 15–25 mg/kg/day. Prednisone 1–2 mg/kg/day is given for 5–7 days and progressively reduced to discontinuation in 6–8 weeks. Drug sensitivity testing is essential. Pericardiectomy is reserved for recurrent effusions or continued elevation of central venous pressure after 4–6 weeks of antituberculous and corticosteroid therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Fig. 1
Fig. 2

Similar content being viewed by others

Notes

  1. Use of trade names is for product identification purposes only and does not imply endorsement.

References

  1. Maisch B, Ristić AD. The classification of pericardial disease in the age of modern medicine. Curr Cardiol Rep 2002; 4(1): 13–21

    Article  PubMed  Google Scholar 

  2. Maisch B, Ristić AD, Pankuweit S. Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone: the way to avoid side effects of systemic corticosteroid therapy. Eur Heart J 2002; 23: 1503–8

    Article  PubMed  CAS  Google Scholar 

  3. Spodick DH. Infectious pericarditis. In: Spodick DH, editor. The pericardium: a comprehensive textbook. New York: Marcel Dekker, 1997: 260–90

    Google Scholar 

  4. Shabetai R. The pericardium. Boston (MA): Kluwer Academic Publishers, 2003

    Google Scholar 

  5. Boyle JO, Pearce ML, Guze LB. Purulent pericarditis: review of the literature and report of eleven cases [letter]. Medicine (Baltimore) 1961; 40: 119

    Google Scholar 

  6. Brook I, Frazier EH. Microbiology of acute purulent pericarditis: a 12-year experience in a military hospital. Arch Intern Med 1996; 156(16): 1857–60

    Article  PubMed  CAS  Google Scholar 

  7. El Hassan N, Dbaibo G, Diab K, et al. Pseudomonas pericarditis in an immunocompetent newborn: unusual presentation with review of the literature. J Infect 2002; 44(1): 49–51

    Article  PubMed  CAS  Google Scholar 

  8. Badawi R, Nageh T, Walker D, et al. Nontyphoidal salmonella pericarditis: a case of Salmonella typhimurium phage type 2 pericarditis. Int J Cardiol 2002; 82(2): 187–9

    Article  PubMed  Google Scholar 

  9. Schaumann R, Ponisch W, Helbig JH, et al. Pericarditis after allogeneic peripheral blood stem cell transplantation caused by Legionella pneumophila (non-serogroup 1). Infection 2001; 29(1): 51–3

    Article  PubMed  CAS  Google Scholar 

  10. Altemeier WA, Tonelli MR, Aitken ML. Pseudomonal pericarditis complicating cystic fibrosis. Pediatr Pulmonol 1999; 27(1): 62–4

    Article  PubMed  CAS  Google Scholar 

  11. Rubin RH, Moellering Jr RC. Clinical, microbiologic and therapeutic aspects of purulent pericarditis. Am J Med 1975; 59(1): 68–78

    Article  PubMed  CAS  Google Scholar 

  12. Klacsmann PG, Bulkley BH, Hutchins GM. The changed spectrum of purulent pericarditis: an 86 year autopsy experience in 200 patients. Am J Med 1977; 63: 666–73

    Article  PubMed  CAS  Google Scholar 

  13. Keersmaekers T, Elshot SR, Sergeant PT. Primary bacterial pericarditis. Acta Cardiol 2002; 57(5): 387–9

    Article  PubMed  Google Scholar 

  14. Singh NP, Prakash A, Makhija A, et al. Staphylococcal pericarditis in a chronic renal failure patient. Ren Fail 2003; 25(3): 493–8

    Article  PubMed  CAS  Google Scholar 

  15. Deng YB, Chang Q, Xiang HJ, et al. Echocardiographic diagnosis and follow-up of left ventricular pseudoaneurysm complicating bacterial pericarditis. J Clin Ultrasound 2003; 31(1): 48–50

    Article  PubMed  Google Scholar 

  16. Kohl O, Schaffer R, Doppl W. Purulent pericarditis as an initial manifestation of esophageal carcinoma [in German]. Dtsch Med Wochenschr 1999; 124(13): 381–5

    Article  PubMed  CAS  Google Scholar 

  17. Muto M, Ohtsu A, Boku N, et al. Streptococcus milled infection and pericardial abscess associated with esophageal carcinoma: report of two cases. Hepatogastroenterology 1999; 46(27): 1782–4

    PubMed  CAS  Google Scholar 

  18. Choi JB, Lee SY, Jeong JW. Delayed diagnosis of purulent pericarditis caused by esophagopericardial fistula by computed tomography scan and echocardiography. Eur J Cardiothorac Surg 2001; 20(6): 1267–9

    Article  PubMed  CAS  Google Scholar 

  19. Touati GD, Carmi D, Nzomvuama A, et al. Purulent pericarditis caused by malignant oesophago-pericardial fistula. Eur J Cardiothorac Surg 2003; 24(5): 847–9

    Article  PubMed  Google Scholar 

  20. Aranda Jr J, Tauth J, Henning RJ, et al. Pseudoaneurysm of the thoracic aorta presenting as purulent pericarditis and pericardial effusion. Cathet Cardiovasc Diagn 1998; 43(1): 63–7

    Article  PubMed  Google Scholar 

  21. Alter P, Schaefer JR, Herzum M, et al. Early occurrence of septic pericarditis after Nissen fundoplication. Am J Med 2003; 115(6): 507–8

    Article  PubMed  Google Scholar 

  22. Sankari A, Kumar AN, Kabins S, et al. Staphylococcal pericarditis following percutaneous transluminal coronary angioplasty. Catheter Cardiovasc Interv 2000; 50(1): 71–3

    Article  PubMed  CAS  Google Scholar 

  23. Mitchell JH, Fraizer MC, Thet LA, et al. Purulent pericarditis induced by endobronchial needle injection of adenoviral-mediated gene therapy. Can J Cardiol 2003; 19(12): 1421–3

    PubMed  Google Scholar 

  24. Ho JS, Flamm SD, Cook PJ. Purulent and constrictive pericarditis arising from a staphylococcal lumbar infection. Tex Heart Inst J 2001; 28(3): 212–4

    PubMed  CAS  Google Scholar 

  25. Brook I. Pericarditis due to anaerobic bacteria. Cardiology 2002; 97(2): 55–8

    Article  PubMed  CAS  Google Scholar 

  26. Sagrista-Sauleda J, Barrabes JA, Permanyer-Miralda G, et al. Purulent pericarditis: review of a 20-year experience in a general hospital. J Am Coll Cardiol 1993; 22: 1661–5

    Article  PubMed  CAS  Google Scholar 

  27. Goodman LJ. Purulent pericarditis. Curr Treat Options Cardiovasc Med 2000; 2(4): 343–50

    Article  PubMed  Google Scholar 

  28. Defouilloy C, Meyer G, Slama M, et al. Intrapericardial fibrinolysis: a useful treatment in the management of purulent pericarditis. Intensive Care Med 1997; 23: 117–8

    Article  PubMed  CAS  Google Scholar 

  29. Ustunsoy H, Celkan MA, Sivrikoz MC, et al. Intrapericardial fibrinolytic therapy in purulent pericarditis. Eur J Cardiothorac Surg 2002; 22(3): 373–6

    Article  PubMed  Google Scholar 

  30. Sagrista-Sauleda J, Permanyer-Miralda G, Soler-Soler J. Tuberculous pericarditis: ten year experience with a prospective protocol for diagnosis and treatment. J Am Coll Cardiol 1988; 11(4): 724–8

    Article  PubMed  CAS  Google Scholar 

  31. Fowler NO. Tuberculous pericarditis. JAMA 1991; 266(1): 99–103

    Article  PubMed  CAS  Google Scholar 

  32. McCaughan BC, Schaff HV, Piehler JM, et al. Early and late results of pericardiectomy for constrictive pericarditis. J Thorac Cardiovasc Surg 1985; 89: 340–50

    PubMed  CAS  Google Scholar 

  33. Long R, Younes M, Patton N, et al. Tuberculous pericarditis: long-term outcome in patients who received medical therapy alone. Am Heart J 1989; 117(5): 1133–9

    Google Scholar 

  34. Strang JI, Kakaza HH, Gibson DG, et al. Controlled clinical trial of complete open surgical drainage and of prednisolone in treatment of tuberculous pericardial effusion in Transkei. Lancet 1988; II(8614): 759–64

    Article  Google Scholar 

  35. Godfrey-Faussett P. Molecular diagnosis of tuberculosis: the need for new diagnostic tools. Thorax 1995; 50(7): 709–11

    Article  PubMed  CAS  Google Scholar 

  36. Seino Y, Ikeda U, Kawaguchi K, et al. Tuberculosis pericarditis presumably diagnosed by polymerase chain reaction analysis. Am Heart J 1993; 126: 249–51

    Article  PubMed  CAS  Google Scholar 

  37. Strang JI. Rapid resolution of tuberculous pericardial effusion with high dose prednisone and antituberculous drugs. J Infect 1994; 28: 251–4

    Article  PubMed  CAS  Google Scholar 

  38. Alzeer AM, Fitzgerald JM. Corticosteroids and tuberculosis: risks and use as adjunct therapy. Tuber Lung Dis 1993; 74: 6–11

    Article  PubMed  CAS  Google Scholar 

  39. Miller WI, Osborn MJ, Sinak LJ, et al. Pyopneumopericardium attributed to an esophagopericardial fistula: report of a survivor and review of the literature. Mayo Clin Proc 1991; 66: 1041–5

    Article  PubMed  CAS  Google Scholar 

  40. Permanyer-Miralda G, Sagrista-Sauleda J, Soler-Soler J. Primary acute pericardial disease: a prospective series of 231 consecutive patients. Am J Cardiol 1985; 56: 623–30

    Article  PubMed  CAS  Google Scholar 

  41. Sexton DJ, Corey GR. Purulent pericarditis. UpToDate Version 11.3 [online]. Available from URL: http://www.uptodateonline.com/application/topic.asp?file=bact_inf/40290&type=A&selectedtitle=1R6 [Accessed 2004 Jan 20]

  42. Estok L, Wallach F. Cardiac tamponade in a patient with AIDS: a review of pericardial disease in patients with HIV infection. Mt Sinai J Med 1998; 65(1): 33–9

    PubMed  CAS  Google Scholar 

  43. DeCastro S, Migliau G, Silvestri A, et al. Heart involvement in AIDS: a prospective study during various stages of the disease. Eur Heart J 1992; 13: 1452–9

    CAS  Google Scholar 

  44. Nathan PE, Arsura EL, Zappi M. Pericarditis with tamponade due to cytomegalovirus and the acquired immunodeficiency syndrome. Chest 1991; 99:765–6

    Article  PubMed  CAS  Google Scholar 

  45. Toma E, Poisson M, Ciaessens MR, et al. Herpes simplex type 2 pericarditis and bilateral facial palsy in patients with AIDS. J Infect Dis 1989; 160: 553–4

    Article  PubMed  CAS  Google Scholar 

  46. Brivet P, Livartowski J, Herve P, et al. Pericardial cryptococcal disease in acquired immunodeficiency syndrome [letter]. Am J Med 1987; 82: 1273

    Article  PubMed  CAS  Google Scholar 

  47. Chen Y, Brennessel D, Walters J, et al. Human immunodeficiency virus-associated pericardial effusion: report of 40 cases and review of literature. Am Heart J 1999; 137: 516–21

    Article  PubMed  CAS  Google Scholar 

  48. Fink L, Reicheck N, Sutton MG. Cardiac abnormalities in acquired immune deficiency syndrome. Am J Cardiol 1984; 54: 1161–3

    Article  PubMed  CAS  Google Scholar 

  49. Silva-Cardoso J, Moura B, Martins L, et al. Pericardial involvement in human immunodeficiency virus infection. Chest 1999; 115: 418–22

    Article  PubMed  CAS  Google Scholar 

  50. Moore M, McCray E, Onorato I. The proportion of US tuberculosis cases with a match in the AIDS registry [abstract]. Am J Respir Crit Care Med 1997; 155: A23

    Google Scholar 

  51. Onorato IM, McCray E. Prevalence of human immunodeficiency virus infection among patients attending tuberculosis clinics in the United States. J Infect Dis 1992; 165(1): 87–92

    Article  PubMed  CAS  Google Scholar 

  52. Centers for Disease Control and Prevention. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. MMWR Morb Mortal Wkly Rep 1998; 47(RR-20): 1–51

    Google Scholar 

  53. Fowler NO, Manitsas GT. Infectious pericarditis. Prog Cardiovasc Dis 1973; 16(3): 323–36

    Article  PubMed  CAS  Google Scholar 

  54. Cegielski JP, Lwakatare J, Dukes CS, et al. Tuberculous pericarditis in Tanzanian patients with and without HIV infection. Tuber Lung Dis 1994; 75(6): 429–34

    Article  PubMed  CAS  Google Scholar 

  55. Rooney JJ, Crocco JA, Lyons HA. Tuberculous pericarditis. Ann Intern Med 1970; 72: 73–81

    PubMed  CAS  Google Scholar 

  56. Ewer K, Deeks J, Alvarez L, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003; 361(9364): 1168–73

    Article  PubMed  Google Scholar 

  57. Maisch B, Maisch S, Kochsiek K. Immune reactions in tuberculous and chronic constrictive pericarditis. Am J Cardiol 1982; 50: 1007–13

    Article  PubMed  CAS  Google Scholar 

  58. Meyers DG, Meyers RE, Prendergast TW. The usefulness of diagnostic tests on pericardial fluid. Chest 1997; 111(5): 1213–21

    Article  PubMed  CAS  Google Scholar 

  59. Garcia LW, Ducatman BS, Wang HH. The value of multiple fluid specimens in the cytological diagnosis of malignancy. Mod Pathol 1994; 7(6): 665–8

    PubMed  CAS  Google Scholar 

  60. Burgess LJ, Reuter H, Carstens ME, et al. The use of adenosine deaminase and interferon-gamma as diagnostic tools for tuberculous pericarditis. Chest 2002; 122(3): 900–5

    Article  PubMed  CAS  Google Scholar 

  61. Seo T, Ikeda Y, Onaka H, et al. Usefulness of serum CA125 measurement for monitoring pericardial effusion. Jpn Circ J 1993; 57(6): 489–94

    Article  PubMed  CAS  Google Scholar 

  62. Fijalkowska A, Szturmowicz M, Tomkowski W, et al. The value of measuring adenosine deaminase activity in pericardial effusion fluid for diagnosing the etiology of pericardial effusion. Pneumonol Alergol Pol 1996; 64 Suppl. 2: 174–9

    PubMed  Google Scholar 

  63. Koh KK, Kim EJ, Cho CH, et al. Adenosine deaminase and carcinoembryonic antigen in pericardial effusion diagnosis, especially in suspected tuberculous pericarditis. Circulation 1994; 89(6): 2728–35

    Article  PubMed  CAS  Google Scholar 

  64. Komsuoglu B, Goldeli O, Kulan K, et al. The diagnostic and prognostic value of adenosine deaminase in tuberculous pericarditis. Eur Heart J 1995; 16: 1126–30

    PubMed  CAS  Google Scholar 

  65. Aggeli C, Pitsavos C, Brili S, et al. Relevance of adenosine deaminase and lysozyme measurements in the diagnosis of tuberculous pericarditis. Cardiology 2000; 94(2): 81–5

    Article  PubMed  CAS  Google Scholar 

  66. Dogan R, Demircin M, Sarigul A, et al. Diagnostic value of adenosine deaminase activity in pericardial fluids. J Cardiovasc Surg (Torino) 1999; 40(4): 501–4

    CAS  Google Scholar 

  67. Burgess LJ, Reuter H, Taljaard JJ, et al. Role of biochemical tests in the diagnosis of large pericardial effusions. Chest 2002; 121(2): 495–9

    Article  PubMed  CAS  Google Scholar 

  68. Lee JH, Lee CW, Lee SG, et al. Comparison of polymerase chain reaction with adenosine deaminase activity in pericardial fluid for the diagnosis of tuberculous pericarditis. Am J Med 2002; 113(6): 519–21

    Article  PubMed  CAS  Google Scholar 

  69. Levy PY, Corey R, Berger P, et al. Etiologic diagnosis of 204 pericardial effusions. Medicine (Baltimore) 2003; 82(6): 385–91

    Article  Google Scholar 

  70. Catanzaro A, Perry S, Clarridge JE, et al. The role of clinical suspicion in evaluating a new diagnostic test for active tuberculosis: results of a multicenter prospective trial. JAMA 2000; 283(5): 639–45

    Article  PubMed  CAS  Google Scholar 

  71. Roberts GD, Goodman NL, Heifets L, et al. Evaluation of the BACTEC radiometric method for recovery of mycobacterium tuberculosis from acid-fast smear-positive specimens. J Clin Microbiol 1983; 18: 689–96

    PubMed  CAS  Google Scholar 

  72. Horsburgh Jr CR, Feldman S, Ridzon R. Practice guidelines for the treatment of tuberculosis: Infectious Diseases Society of America. Clin Infect Dis 2000; 31(3): 633–9

    Article  PubMed  Google Scholar 

  73. Nugue O, Millaire A, Porte H, et al. Pericardioscopy in the etiologic diagnosis of pericardial effusion in 141 consecutive patients. Circulation 1996; 94(7): 1635–41

    Article  PubMed  CAS  Google Scholar 

  74. Pierce HI, Cooper EB. Meningococcal pericarditis: clinical features and therapy in five patients. Arch Intern Med 1972; 129: 918–22

    Article  PubMed  CAS  Google Scholar 

  75. Morse JR, Oretsky MI, Hudson JAM. Pericarditis as a complication of meningococcal meningitis. Ann Intern Med 1971; 74: 212–7

    PubMed  CAS  Google Scholar 

  76. Schrank J, Dooley D. Purulent pericarditis caused by Candida species: case report and review. Clin Infect Dis 1995; 21: 182–7

    Article  PubMed  Google Scholar 

  77. Kraus WE, Valenstein PN, Corey GR. Purulent pericarditis caused by Candida: report of three cases and identification of high-risk populations as an aid to early diagnosis. Rev Infect Dis 1988; 10(1): 34–41

    Article  PubMed  CAS  Google Scholar 

  78. Martineau AR, Beeching NJ, Nye FJ, et al. Serum and pericardial fluid bactericidal assays in a patient with staphylococcal pericarditis. J Infect 2001; 43(2): 158–9

    Article  PubMed  CAS  Google Scholar 

  79. Scheid WM, Sande MA. Endocarditis and intravascular infections. In: Mandell GL, Bennett JE, Dolin R, editors. Mandel, Douglas and Bennett’s principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995: 740–56

    Google Scholar 

  80. Chuard C, Herrmann M, Vaudaux P, et al. Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations. Antimicrob Agents Chemother 1991; 35(12): 2611–6

    Article  PubMed  CAS  Google Scholar 

  81. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. MMWR Recomm Rep 1994; 43(RR13): 1–132

    Google Scholar 

  82. Dwivedi SK, Rastogi P, Saran RK, et al. Antitubercular treatment does not prevent constriction in chronic pericardial effusion of undetermined etiology: a randomized trial. Indian Heart J 1997; 49(4): 411–4

    PubMed  CAS  Google Scholar 

  83. Sumartojo E. When tuberculosis treatment fails: a social behavioral account of patient adherence. Am Rev Respir Dis 1993; 147: 1311–20

    PubMed  CAS  Google Scholar 

  84. Senderovitz T, Viskum K. Corticosteroids and tuberculosis. Respir Med 1994; 88: 561–5

    Article  PubMed  CAS  Google Scholar 

  85. Mayosi BM, Ntsekhe M, Volmink JA, et al. Interventions for treating tuberculous pericarditis. Cochrane Database Syst Rev 2002; (4): CD000526

    PubMed  Google Scholar 

  86. Juneja R, Kothari SS, Saxena A, et al. Intrapericardial streptokinase in purulent pericarditis. Arch Dis Child 1999; 80: 275–7

    Article  PubMed  CAS  Google Scholar 

  87. Maisch B, Ristić AD. Practical aspects of the management of pericardial disease. Heart 2003; 89: 1096–103

    Article  PubMed  Google Scholar 

  88. Maisch B, Adler Y, Erbel R, et al. Guidelines of the European Society of Cardiology: diagnosis and management of pericardial diseases. Eur Heart J 2004; 25(7): 587–610

    Article  PubMed  Google Scholar 

  89. Van Trigt P, Douglas J, Smith PK, et al. A prospective trial of subxiphoid pericardiotomy in the diagnosis and treatment of large pericardial effusions: follow-up report. Ann Surg 1993; 218: 777–82

    Article  PubMed  Google Scholar 

  90. Campione A, Cacchiarelli M, Ghiribelli C, et al. Which treatment in pericardial effusion? J Cardiovasc Surg (Torino) 2002; 43(5): 735–9

    CAS  Google Scholar 

  91. Mann-Segal DD, Shanahan EA, Jones B, et al. Purulent pericarditis: rediscovery of an old remedy. J Thorac Cardiovasc Surg 1996; 111: 487–8

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors greatly appreciate receiving a grant from the German Science Foundation (Deutsche Forschungsgemeinschaft — DFG) for Prof. Dr B. Maisch and the Research Fellowship from the European Society of Cardiology for Dr A.D. Risti ć. There is no potential conflict of interest.

Author information

Authors and Affiliations

  1. Faculty of Medicine, Department of Internal Medicine — Cardiology, Philipps University, Marburg Baldingerstrasse 1, Marburg, D-35033, Germany

    Sabine Pankuweit, Arsen D. Ristić &  Bernhard Maisch

  2. University Institute for Cardiovascular Diseases, Clinical Center of Serbia, Belgrade, Serbia, and Montenegro

    Arsen D. Ristić & Petar M. Seferović

Authors
  1. Sabine Pankuweit
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arsen D. Ristić
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Petar M. Seferović
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bernhard Maisch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bernhard Maisch.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pankuweit, S., Ristić, A.D., Seferović, P.M. et al. Bacterial Pericarditis. Am J Cardiovasc Drugs 5, 103–112 (2005). https://doi.org/10.2165/00129784-200505020-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00129784-200505020-00004

Keywords

Search

Navigation